Michael D. Hambuchen

Pharmacology, Toxicology and PharmaceuticsNeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The Development and Characterization of an scFv-Fc Fusion–Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse”.

The Development and Characterization of an scFv-Fc Fusion–Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse

Journal of Pharmacology and Experimental Therapeutics(2020)10.1124/jpet.119.261180

N/A

0DataRank · unranked

28 citations

Laura Ewing, Michael D. Hambuchen, Shannon M. Zintner, Juliana C. Small, Caleb Bolden +5 more

Optimization of (Dithioperoxo)thiolate-Based Antifungal Agents for Triazole-Resistant Aspergillus Fumigatus

Pathogens(2025)10.3390/pathogens14090878

N/A

0DataRank · unranked

0 citations

Kebba Jobe, Melinda E. Varney, Michael D. Hambuchen, A.R.M. Ruhul Amin, Timothy E. Long +1 more